Australian cannabis producer Little Green Pharma struck a deal to supply high-THC medical marijuana to Cologne, Germany-based Cannamedical.
It’s the fourth medical cannabis supply agreement the Australian company has inked with wholesalers and distributors in Germany.
The Western Australia-based company’s previous deals were with:
- Four20 Pharma.
- Illios Sante.
- Demecan.
The cannabis for the latest contract will come from Little Green Pharma’s wholly owned subsidiary in Denmark, the company said in a news release.
The product has a potential value of more than $4.5 million (3 million euros) over two years.
Cannamedical has licenses to import medical marijuana into Germany, where it’s distributed or exported within the European Union.
